Effect of non-peptide tachykinin NK1 receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea

被引:18
|
作者
Khawaja, AM [1 ]
Liu, YC [1 ]
Rogers, DF [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England
关键词
CGP; 49823; 55000; CP 99,994; MEN 10,627; mucus; tachykinin; tachykinin receptor; tachykinin receptor antagonist;
D O I
10.1016/S0014-2999(99)00694-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated, in ferret trachea in vitro, the binding characteristics and the inhibition of non-adrenergic, non-cholinergic (NANC) neural mucus secretion of four tachykinin receptor antagonists: the non-peptide tachykinin NK1 receptor antagonists CGP 49823 ((2R,4S)-2-benzyl-1-(3,5-dimethylbenzoyl)-4-(quinolin-mu-ylmethl amino) piperidine) and CGP 55000 ((2R,4S)-2-benzyl-1-(3,5-bistrifluoromethyl-benzoyl)-4-(quinolinyl-methylamino)piperidine) and CP 99,994 ((+)-(2S,3S)-3-methoxybenzyl amino)-2-phenylpiperidine), and the peptide tachykinin NK2 receptor antagonist MEN 10,627 (cyclo(Met-Asp-Trp-Phe-Dap-Leu)cyclo(2 beta-5 beta)). CGP 49823, CGP 55000 and CP 99,994 concentration-dependently displaced [I-125]Bolton-Hunter substance P binding in tracheal membranes with Hill coefficients not different from unity and IC50 values of 1.4, 1.7 and 1.3 nM, respectively. In contrast, MEN 10,627 displaced binding according to a two-site model, with IC(50)s of 0.2 nM and 1.3 mu M. Electrical stimulation of tracheal segments with adrenoceptor and cholinoceptor blockade increased output of the mucus marker (SO4)-S-35 by 59% above baseline (representing the NANC neural secretory response). CGP 49823, CGP 55000 or CP 99,994 concentration-dependently inhibited NANC neural secretion with IC50 values of 30, 8 and 120 nM, respectively. In contrast, MEN 10,627 (3 mu M) did not inhibit secretion. The NK1 antagonists, but not the NK2 antagonist, inhibited [Sar(9)]substance P-induced secretion, while none of the antagonists affected acetylcholine-induced secretion. We conclude that NANC neural secretion in ferret trachea in vitro is a useful test system for tachykinin NK1 receptor antagonists with therapeutic potential in conditions of the airways in which tachykininergic mechanisms and mucus hypersecretion are implicated in pathophysiology, for example asthma and chronic bronchitis. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:173 / 181
页数:9
相关论文
共 50 条
  • [41] NON-ADRENERGIC, NON-CHOLINERGIC NEUROGENIC RELAXATION MEDIATED BY VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN THE ISTHMUS OF THE HUMAN FALLOPIAN-TUBE
    OWMAN, C
    HELM, G
    SJOBERG, NO
    INTERNATIONAL JOURNAL OF FERTILITY, 1983, 28 (01) : 12 - 12
  • [42] Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists
    Boden, P
    Eden, JM
    Hodgson, J
    Horwell, DC
    Hughes, J
    McKnight, AT
    Lewthwaite, RA
    Pritchard, MC
    Raphy, J
    Meecham, K
    Ratcliffe, GS
    SumanChauhan, N
    Woodruff, GN
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (08) : 1664 - 1675
  • [43] Endomorphins 1 and 2 reduce relaxant non-adrenergic, non-cholinergic neurotransmission in rat gastric fundus
    Storr, M
    Gaffal, E
    Schusdziarra, V
    Allescher, HD
    LIFE SCIENCES, 2002, 71 (04) : 383 - 389
  • [44] Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety
    Giuliani, Germano
    Cappelli, Andrea
    Matarrese, Mario
    Masiello, Valeria
    Turolla, Elia Anna
    Monterisi, Cristina
    Fazio, Ferruccio
    Anzini, Maurizio
    Mohr, Gal la Pericot
    Riitano, Daniela
    Finetti, Federica
    Morbidelli, Lucia
    Ziche, Marina
    Giorgi, Gianluca
    Vomero, Salvatore
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (07) : 2242 - 2251
  • [45] Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro
    Liu, YC
    Khawaja, AM
    Rogers, DF
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (06) : 1353 - 1359
  • [46] VAGAL NON-ADRENERGIC, NON-CHOLINERGIC (NANC) CONTROL OF PANCREATIC ELECTROLYTE AND ENZYME-SECRETION IN THE GUINEA-PIG
    BUCHAN, AMJ
    DAVISON, JS
    DICKSON, V
    JOURNAL OF PHYSIOLOGY-LONDON, 1984, 346 (JAN): : P117 - P117
  • [47] EFFECTS OF AN NK1 RECEPTOR SELECTIVE ANTAGONIST, FK888, ON MUCUS SECRETION IN FERRET TRACHEA - INVOLVEMENT OF TACHYKININS IN NEURAL MUCUS SECRETION
    HIRAYAMA, Y
    RAMNARINE, SI
    FUJII, T
    BARNES, PJ
    ROGERS, DF
    REGULATORY PEPTIDES, 1992, : S72 - S72
  • [48] EPITHELIAL MODULATION OF NON-ADRENERGIC, NON-CHOLINERGIC AND VASOACTIVE INTESTINAL PEPTIDE-INDUCED RESPONSES - ROLE OF NEUTRAL ENDOPEPTIDASE
    RHODEN, KJ
    BARNES, PJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 171 (2-3) : 247 - 250
  • [49] SIMILARITIES BETWEEN THE RELAXATIONS INDUCED BY VASOACTIVE INTESTINAL PEPTIDE AND BY STIMULATION OF THE NON-ADRENERGIC NON-CHOLINERGIC NEURONS IN THE RAT STOMACH
    KAMATA, K
    SAKAMOTO, A
    KASUYA, Y
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1988, 338 (04) : 401 - 406
  • [50] THE ENKEPHALIN ANALOG HOE-825 INHIBITS THE EFFECT OF THE NON-ADRENERGIC, NON-CHOLINERGIC INHIBITORY NERVOUS PATHWAY
    JANSSENS, J
    VANTRAPPEN, G
    CECCATELLI, P
    DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (08) : 774 - 774